Biotech/Healthcare are certainly seeing inflows of money from institutions. The RS on this name along with the clear volume accumulation is really nice. Potential consolidation into ATH Breakout.
Investor, Trader, Prolific Tweeter - Taking anything I say as advice wouldn’t be advisable. My opinions are probably someone else’s.
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
Investor, Trader, Prolific Tweeter - Taking anything I say as advice wouldn’t be advisable. My opinions are probably someone else’s.
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。